BioXcel Therapeutics, Inc. 8-K Filing

From the Filing

EDGAR Filing Documents for 0001104659-26-038174 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001104659-26-038174 Filing Date 2026-04-01 Accepted 2026-04-01 06:58:25 Documents 11 Period of Report 2026-04-01 Items Item 8.01: Other Events Interactive Data Document Format Files Seq Description Document Type Size 1 FORM 8-K tm2610820d1_8k.htm iXBRL 8-K 23552 Complete submission text file 0001104659-26-038174.txt 186369 Data Files Seq Description Document Type Size 2 XBRL TAXONOMY EXTENSION SCHEMA btai-20260401.xsd EX-101.SCH 3047 3 XBRL TAXONOMY EXTENSION LABEL LINKBASE btai-20260401_lab.xml EX-101.LAB 34239 4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btai-20260401_pre.xml EX-101.PRE 22380 14 EXTRACTED XBRL INSTANCE DOCUMENT tm2610820d1_8k_htm.xml XML 3090 Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060 BioXcel Therapeutics, Inc. (Filer) CIK : 0001720893 (see all company filings) EIN. : 821386754 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-38410 | Film No.: 26824636 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)